Literature DB >> 8311689

Assessment of the influence of subacute phenobarbitone administration on multi-tissue cell proliferation in the rat using bromodeoxyuridine immunocytochemistry.

H B Jones1, N A Clarke.   

Abstract

The effects of daily administration of phenobarbitone on the mitotic rates of several tissues were investigated by bromodeoxyuridine (BrdU) immunocytochemistry. Phenobarbitone (80 mg/kg per day) was dosed to AP Wistar male rats for up to 7 days and BrdU (10 mg/ml) was given by infusion at a rate of 10 microliters/h via subcutaneously implanted osmotic minipumps for 2 days prior to necropsy on days 1, 2, 3, 5 and 7. BrdU-labelled nuclei were visualised by peroxidase-antiperoxidase immunocytochemistry and counts of the numbers of labelled cells (labelling index, LI%) made from at least 1000 cells per tissue section(s). The LIs of several tissues (testis, adrenal cortex and medulla, kidney distal convoluted tubule and exocrine pancreas) showed no statistical difference by comparison with controls. Several tissues exhibited characteristic responses to phenobarbitone administration. Pituitary and endocrine pancreas LIs were decreased while those of thyroid, liver and kidney proximal convoluted tubule were increased. The pattern of LI increase was unique to each tissue with liver (median and lateral lobes) increased two-fold on day 3 and returning to control levels thereafter while kidney proximal tubule LI rose gradually with time and remained elevated on day 7. Thyroid LI on day 1 was almost double that of day 0 control and increased steadily thereafter. These data illustrate the varied responses of different tissues to phenobarbitone exposure, namely, depression and stimulation of mitosis. The causation of these functional changes is discussed in relation to direct and indirect effects on functional parameters, especially enzyme induction, alterations in hormonal and growth factor status and receptor regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8311689     DOI: 10.1007/bf01974069

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  30 in total

Review 1.  Too many rodent carcinogens: mitogenesis increases mutagenesis.

Authors:  B N Ames; L S Gold
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

Review 2.  Mouse liver tumors and microsomal enzyme-inducing drugs: experimental and clinical perspectives with phenobarbital.

Authors:  R M McClain
Journal:  Prog Clin Biol Res       Date:  1990

3.  Regulation of the alpha and thyrotropin beta-subunit messenger ribonucleic acids by thyroid hormones.

Authors:  W W Chin; M A Shupnik; D S Ross; J F Habener; E C Ridgway
Journal:  Endocrinology       Date:  1985-03       Impact factor: 4.736

4.  The effect of phenobarbital on the metabolism and excretion of thyroxine in rats.

Authors:  R M McClain; A A Levin; R Posch; J C Downing
Journal:  Toxicol Appl Pharmacol       Date:  1989-06-15       Impact factor: 4.219

Review 5.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

6.  Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene.

Authors:  M L Cunningham; J Foley; R R Maronpot; H B Matthews
Journal:  Toxicol Appl Pharmacol       Date:  1991-03-01       Impact factor: 4.219

7.  Phenobarbital induction of cytochrome P-450 in normal and preneoplastic rat liver: comparison of enzyme and mRNA expression as detected by immunohistochemistry and in situ hybridization.

Authors:  M Schwarz; G Peres; A Buchmann; T Friedberg; D J Waxman; W Kunz
Journal:  Carcinogenesis       Date:  1987-09       Impact factor: 4.944

8.  Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats.

Authors:  V De Sandro; M Chevrier; A Boddaert; C Melcion; A Cordier; L Richert
Journal:  Toxicol Appl Pharmacol       Date:  1991-11       Impact factor: 4.219

9.  Dose-dependent acinar induction of cytochromes P450 in rat liver. Evidence for a differential mechanism of induction of P450IA1 by beta-naphthoflavone and dioxin.

Authors:  R G Bars; C R Elcombe
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

10.  Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital.

Authors:  R M McClain; R C Posch; T Bosakowski; J M Armstrong
Journal:  Toxicol Appl Pharmacol       Date:  1988-06-30       Impact factor: 4.219

View more
  3 in total

1.  Assessment of the labelling index of cohorts of the pancreatic islet cell population in phenobarbitone-treated male rats using a double immunohistochemical technique for 5-bromo-2'-deoxyuridine and pancreatic hormones.

Authors:  H B Jones; S J Harbottle; A L Bowdler
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

2.  Induction of cell proliferation in the rat liver by the short-term administration of ethyl tertiary-butyl ether.

Authors:  Anna Kakehashi; Akihiro Hagiwara; Norio Imai; Min Wei; Shoji Fukushima; Hideki Wanibuchi
Journal:  J Toxicol Pathol       Date:  2015-01-06       Impact factor: 1.628

3.  Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling.

Authors:  Anna Kakehashi; Ayumi Kato; Naomi Ishii; Min Wei; Keiichirou Morimura; Shoji Fukushima; Hideki Wanibuchi
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.